Last updated on 20 November 2026
To maximise the impact of the projects it funds and improve the clarity and visibility of its funding schemes, the French National Agency for Research on AIDS, Viral Hepatitis and Emerging Infectious Diseases (ANRS MIE) is evolving its funding opportunities in 2027.
This development is based on three main priorities:
The generic Call for Projects and the Start programme’s Call for Applications will open on 15 January 2027, with a closing date scheduled for mid-March.
Targeted Calls for Projects may cover all the Agency’s thematic areas and research disciplines (basic, translational and clinical research, public health, and social sciences and humanities). They will be announced in early 2027 and are expected to open in the second half of the year.
Since its establishment in 2021 in response to the COVID-19 pandemic, ANRS MIE has expanded the scope of its activities in research promotion, evaluation, coordination and funding to include emerging and re-emerging infectious diseases (ERIDs). This expansion has led ANRS MIE to increase its funding opportunities, moving within just a few years from two recurring Calls for Projects within its historical scope to around ten calls per year covering all its areas of activity.
This development has supported strong research momentum across the Agency’s thematic areas, demonstrating the responsiveness and excellence of its partner institutions and research teams. A major driver of this momentum, particularly during health crises, has been the Agency’s ability to steer and guide research. The ANRS MIE International Scientific Council has therefore recommended strengthening this role by placing greater emphasis on research steering and the prioritisation of research objectives within the Agency’s funding strategy.
ANRS MIE is therefore preparing to take a further step in its development by targeting its funding more closely towards scientific priorities, while continuing to support research across its entire scope. The aim is to maximise the impact of the projects funded by the Agency and improve the visibility and clarity of its funding opportunities.
Research funding for emerging and re-emerging infectious diseases (EIDs) will be more strategically focused, with the aim of strengthening our resilience in the face of health crises.
The evolution of research funding for EIDs towards a framework combining flagship programmes (top-down approach) and targeted Calls for Projects will therefore be reinforced. These calls will be open to projects based both in France and in low- and middle-income countries (LMICs).
These targeted Calls for Projects will continue to be complemented by a Call for Projects dedicated to clinical research, developed in line with the procedures of the French Hospital Clinical Research Programme (PHRC): the ReCH-MIE Call for Projects, coordinated by ANRS MIE and funded by the Directorate General for Research, Innovation and Digital Health (DGRINES) of the French Ministry of Health.
For this first year of implementation, further details of these calls will be announced in early 2027, with openings expected in the second half of the year. The actual funding opportunities available in 2027 will partly depend on ANRS MIE’s financial resources, the final amount of which has not yet been determined.
This development will also help consolidate the complementarity between the Agency’s funding schemes and those offered by the French National Research Agency (ANR), while contributing to a clearer national framework for supporting research on emerging and re-emerging infectious diseases.
Within its historical scope (HIV/AIDS, viral hepatitis, STIs and tuberculosis), ANRS MIE intends to maintain strong support for initiatives originating from the scientific community (“bottom-up” approach) through a generic Call for Projects.
In 2027, generic funding schemes will be consolidated around a single annual Call for Projects, opening at the beginning of the year. This research Call for Projects will be open from 15 January to mid-March 2027. It will fund research projects, research grants associated with a project, and research initiation contracts focusing on HIV/AIDS, viral hepatitis, STIs and tuberculosis, both in France and in low- and middle-income countries (LMICs).
In addition, following the approach adopted for emerging and re-emerging infectious diseases and according to the same timetable, a targeted Call for Projects may be launched around mid-year for these thematic areas.
ANRS MIE wishes to strengthen its commitment to the next generation of researchers based in France and in low- and middle-income countries (LMICs) through its Start programme.
This commitment will take the form of an expanded Call for Applications for individual research grants, covering PhD studies, fourth-year PhD funding and postdoctoral research.
From 15 January 2027, this scheme will be open to research covering the Agency’s entire scope: HIV/AIDS, viral hepatitis, STIs, tuberculosis, and emerging and re-emerging infectious diseases. The closing date is scheduled for mid-March.
Finally, ANRS MIE will continue to offer funding opportunities for Master’s scholarships in collaboration with its International Network, scientific conferences and publications, as well as joint Calls for Projects implemented with partner institutions or within European and international consortia (including the European BE READY Partnership and DZIF).
All information about our funding opportunities is available on the ANRS MIE website and social media channels.
All calls for proposals